![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DPP7 |
Gene summary for DPP7 |
![]() |
Gene information | Species | Human | Gene symbol | DPP7 | Gene ID | 29952 |
Gene name | dipeptidyl peptidase 7 | |
Gene Alias | DPP2 | |
Cytomap | 9q34.3 | |
Gene Type | protein-coding | GO ID | GO:0006508 | UniProtAcc | Q9UHL4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
29952 | DPP7 | C04 | Human | Oral cavity | OSCC | 5.18e-09 | 7.02e-01 | 0.2633 |
29952 | DPP7 | C21 | Human | Oral cavity | OSCC | 3.20e-56 | 1.90e+00 | 0.2678 |
29952 | DPP7 | C30 | Human | Oral cavity | OSCC | 1.96e-14 | 1.01e+00 | 0.3055 |
29952 | DPP7 | C38 | Human | Oral cavity | OSCC | 1.47e-21 | 2.05e+00 | 0.172 |
29952 | DPP7 | C43 | Human | Oral cavity | OSCC | 3.04e-13 | 2.47e-01 | 0.1704 |
29952 | DPP7 | C46 | Human | Oral cavity | OSCC | 2.46e-17 | 6.30e-01 | 0.1673 |
29952 | DPP7 | C51 | Human | Oral cavity | OSCC | 4.02e-12 | 8.82e-01 | 0.2674 |
29952 | DPP7 | C57 | Human | Oral cavity | OSCC | 3.75e-07 | 5.97e-01 | 0.1679 |
29952 | DPP7 | C06 | Human | Oral cavity | OSCC | 2.70e-06 | 1.32e+00 | 0.2699 |
29952 | DPP7 | C08 | Human | Oral cavity | OSCC | 8.61e-50 | 9.89e-01 | 0.1919 |
29952 | DPP7 | C09 | Human | Oral cavity | OSCC | 1.24e-35 | 1.24e+00 | 0.1431 |
29952 | DPP7 | LN22 | Human | Oral cavity | OSCC | 4.58e-06 | 1.10e+00 | 0.1733 |
29952 | DPP7 | LN38 | Human | Oral cavity | OSCC | 5.02e-07 | 1.66e+00 | 0.168 |
29952 | DPP7 | LN46 | Human | Oral cavity | OSCC | 3.21e-06 | 6.55e-01 | 0.1666 |
29952 | DPP7 | LP15 | Human | Oral cavity | LP | 2.98e-10 | 1.69e+00 | 0.2174 |
29952 | DPP7 | SYSMH1 | Human | Oral cavity | OSCC | 4.03e-52 | 1.07e+00 | 0.1127 |
29952 | DPP7 | SYSMH2 | Human | Oral cavity | OSCC | 1.32e-24 | 6.89e-01 | 0.2326 |
29952 | DPP7 | SYSMH3 | Human | Oral cavity | OSCC | 1.30e-29 | 7.29e-01 | 0.2442 |
29952 | DPP7 | SYSMH4 | Human | Oral cavity | OSCC | 7.91e-14 | 2.95e-01 | 0.1226 |
29952 | DPP7 | SYSMH6 | Human | Oral cavity | OSCC | 1.96e-32 | 8.47e-01 | 0.1275 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DPP7 | SNV | Missense_Mutation | c.545N>A | p.Ala182Glu | p.A182E | Q9UHL4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A2-A3Y0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR | |
DPP7 | SNV | Missense_Mutation | c.1102N>C | p.Phe368Leu | p.F368L | Q9UHL4 | protein_coding | deleterious(0) | probably_damaging(0.96) | TCGA-BH-A0HA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
DPP7 | deletion | Frame_Shift_Del | novel | c.596delN | p.Asn199ThrfsTer57 | p.N199Tfs*57 | Q9UHL4 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
DPP7 | SNV | Missense_Mutation | rs146742762 | c.1306N>A | p.Val436Ile | p.V436I | Q9UHL4 | protein_coding | tolerated(1) | benign(0.011) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
DPP7 | SNV | Missense_Mutation | c.1205G>A | p.Gly402Asp | p.G402D | Q9UHL4 | protein_coding | tolerated(0.88) | benign(0.003) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR | |
DPP7 | deletion | Frame_Shift_Del | c.1212_1213delCA | p.Arg405SerfsTer55 | p.R405Sfs*55 | Q9UHL4 | protein_coding | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD | |||
DPP7 | deletion | Frame_Shift_Del | c.1205delG | p.Gly402ValfsTer28 | p.G402Vfs*28 | Q9UHL4 | protein_coding | TCGA-NH-A5IV-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
DPP7 | SNV | Missense_Mutation | rs770245778 | c.1303N>A | p.Ala435Thr | p.A435T | Q9UHL4 | protein_coding | deleterious(0) | possibly_damaging(0.661) | TCGA-A5-A0GG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DPP7 | SNV | Missense_Mutation | rs777004339 | c.613N>A | p.Val205Ile | p.V205I | Q9UHL4 | protein_coding | tolerated(0.1) | benign(0.383) | TCGA-AJ-A3BG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
DPP7 | SNV | Missense_Mutation | rs756944196 | c.1219N>A | p.Ala407Thr | p.A407T | Q9UHL4 | protein_coding | tolerated(0.2) | possibly_damaging(0.811) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | CRWCYVOHVXAEMF-LBPRGKRZSA-N | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | BDBM50382283 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | US8470836, 8 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | US8470836, 2 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | inhibitor | 178103152 | ||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | US8470836, 5 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | BDBM50434165 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | BDBM50434164 | |||
29952 | DPP7 | PROTEASE, ENZYME, DRUGGABLE GENOME | US8470836, 6 |
Page: 1 |